<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FC10C2F9-6E9D-47E2-9489-AA868B49F0B4"><gtr:id>FC10C2F9-6E9D-47E2-9489-AA868B49F0B4</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Lomas</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0901786"><gtr:id>C00FCB7F-B3AC-4A42-B7AD-A51F60945D10</gtr:id><gtr:title>Pathobiology of alpha-1-antitrypsin deficency and the serpinopathies</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901786</gtr:grantReference><gtr:abstractText>The serine proteinase inhibitors or serpins are a family of proteins that play an important role in controlling enzymes within the human body. Naturally occurring mutations cause the protein to change shape and accumulate as chains of polymers within the cell of synthesis. This causes cell death and hence either cirrhosis (if the protein accumulates within the liver) or dementia (if it accumulates within the brain). We propose to assess the mechanism by which polymers form and their effect on the cells in which they are synthesised. We also propose to determine the mechanism of action of small molecules that we have identified that can block polymer formation in the test tube and reduce the accumulation of mutant protein in a cell model of disease. We have shown that mutations that favour the formation of polymers also favour the formation of an inactive latent conformation. We propose to develop new monoclonal antibodies to the latent conformation of the serpins alpha-1-antitrypsin and neuroserpin so that we can identify them in biological tissues and so evaluate their role in disease. Polymers of alpha-1-antitrypsin form spontaneously within the lungs of individuals with alpha-1-antitrypsin deficiency where they inactivate alpha-1-antitrypsin as a proteinase inhibitor as well as acting as a chemoattractant to recruit inflammatory cells to the lung. We will use our antibody to polymers of alpha-1-antitrypsin to develop a new assay to image pathological polymers within the lung. This will provide useful information on the clearance of polymers from the lung and perhaps the progression of lung disease in individuals with alpha-1-antitrypsin deficiency.</gtr:abstractText><gtr:technicalSummary>We have used a wide range of techniques to show that naturally occurring mutations in members of the serine proteinase inhibitor (serpin) superfamily result in abberant conformational transitions to cause disease. The most common of these is the sequential linkage between the reactive centre loop of one molecule and beta-sheet A of another. This process of loop-sheet polymerisation results in the retention of ordered serpin polymers within the cell of synthesis. Polymerisation of mutants of antitrypsin, antithrombin, C1 inhibitor and antichymotrypsin cause cirrhosis, thrombosis, angioedema and emphysema respectively. Perhaps most striking is our description of the same process in a neurone specific serpin, neuroserpin, to cause a novel dementia that we have called Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB). A central feature of these conditions is a genotype-phenotype correlation that can be explained by the rate of intracellular polymerisation. In view of their common mechanism we have grouped these diseases of the serpins together as the serpinopathies and have used them as a paradigm for a broader class of disorders that we have called the conformational diseases. The serpinopathies provide a structurally defined model of protein aggregation in association with disease. We propose to use the small molecules, crystal structures, cell lines, monoclonal antibodies, fly models and the genetic screen that were generated in the last programme grant to address the following specific questions: (i) what are the conformational transitions underlying the serpinopathies? (ii) what is the effect of small molecules that block the polymerisation of alpha-1-antitrypsin? (iii) what is the cellular response to the retention of ordered serpin polymers within the endoplasmic reticulum? (iv) can we prepare monoclonal antibodies to latent alpha-1-antitrypsin and neuroserpin in order to define their role in disease? (v) what is the role of polymers in lung disease in alpha-1-antitrypsin deficiency? These studies, although focused on alpha-1-antitrypsin and neuroserpin, are applicable to many of the mutations in serpins that underlie the serpinopathies. The long-term aim of our work is to understand mechanisms of disease caused by the serpinopathies (from pathological conformational transitions to pathways of cell toxicity) so that we can develop novel therapeutic strategies to treat the associated clinical syndromes.</gtr:technicalSummary><gtr:fund><gtr:end>2016-06-06</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2938654</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GSK small molecules to blcok polymeristaion of antitrypsin</gtr:description><gtr:id>FED2E894-78C4-42FF-9BFE-43A40E63D0A6</gtr:id><gtr:impact>On oging</gtr:impact><gtr:outcomeId>Cniomnz7PPN-1</gtr:outcomeId><gtr:partnerContribution>Providing small moelcules as tools to block polymerisation in cell modelsof disease</gtr:partnerContribution><gtr:piContribution>Provided monoclonal antibody, ELISA assay and expertise on the biology of antitrypsin deficiency</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press release Nature paper 2011</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>0FFA6AAE-E8F8-4BDD-BC46-824B54754EBC</gtr:id><gtr:impact>Work featured on the Today programme, Radio 4 Material World, Naked Scientist, BBC website, Guardian website and in newspapers/websites around the world

Huge response from public, especially patients with antitrypsin deficiency</gtr:impact><gtr:outcomeId>QFE3Gbf31TH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1638935</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Senior Clinical Fellowship</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B1B194CE-6FF2-4575-98CD-6CD3F89BB000</gtr:id><gtr:outcomeId>dxawD4P5F1T0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>193232</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CDA2F54B-7A29-4D97-BAA7-548E9FA56C17</gtr:id><gtr:outcomeId>dmNWhAASbB60</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT PhD Training Programme for Clinicians</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>BF4136D8-939F-4008-BFBC-0D869A6A62C6</gtr:id><gtr:outcomeId>EyxJGrLxSZy0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>118690</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BLF June Hancock Mesothelioma Reserch Fund Grant</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>British Lung Foundation (BLF)</gtr:fundingOrg><gtr:id>16D57E62-0EC6-48FC-B837-40F75A620098</gtr:id><gtr:outcomeId>XnEdxbQtMjE0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Amgen Foundation Summer Scholarship 2011 (through University of Cambridge)</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>Amgen Inc</gtr:fundingOrg><gtr:id>6F25FB0E-108D-49AD-93BE-D17FFABF1C8A</gtr:id><gtr:outcomeId>f4eTVUSy1yo0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Cambridge Biomedical Research Centre</gtr:department><gtr:description>NIHR BRC Training &amp;amp; Capacity Builing ast the University of Cambridge</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>5FD02F47-E157-43CA-8C18-A81CA5A51EE4</gtr:id><gtr:outcomeId>Mq3ZeWGpkHn0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CLDF William Holloway Alpha-1 ATD Research Fellowship (PhD Studentship)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Children's Liver Disease Foundation (CLDF)</gtr:fundingOrg><gtr:id>BF1A7F2A-C59C-46FE-9E9A-D2F493BD9680</gtr:id><gtr:outcomeId>hCuhgePr6rG0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>564500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT grant to the Cambrdge University Research Society</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>3ABA8140-F806-4625-8DDF-9F80DCEEBF98</gtr:id><gtr:outcomeId>X5gfuLXvVGf0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/EPSRC Life Science Interface Research Grant</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>839910F5-43FD-491B-8B6F-139B18F21111</gtr:id><gtr:outcomeId>RAQeKhevM270</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT/MRC Neurodegenerative Diseases Strategic Award</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>86B732CD-15C5-4590-B6CA-F4258EA74CA8</gtr:id><gtr:outcomeId>Qfqqey5QVNy1</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>405163</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK grant to develop monoclonal antibodies to detect fragments of surfactant protein D</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>96EBDE36-2868-4B70-A1ED-3905E41AE5B4</gtr:id><gtr:outcomeId>pJsvVknbVPg0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>43859</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Laurell's Training Award</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Grifols</gtr:fundingOrg><gtr:id>0E0FC31D-EAF3-4DCD-B936-E481842414F9</gtr:id><gtr:outcomeId>oh9Lj9ZbwbF0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>27170</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alpha-1 Foundation Pilot &amp;amp; Feasibility Study</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>Alpha-1 Foundation</gtr:fundingOrg><gtr:id>5DFFF9BE-02D6-4095-81D9-C7AC1885FD27</gtr:id><gtr:outcomeId>bffbbcJTWSG0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2467180</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BB/H003843/1 Quantitative approaches to defining normal and aberrant protein homeostasis - co-applicant</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/H003843/1</gtr:fundingRef><gtr:id>EB38C39B-1407-487D-B619-3EAE38DEF018</gtr:id><gtr:outcomeId>SYxb2CRKRZi0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>141477</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT Studentship</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>842C60C1-8C35-4FE4-933D-AE92A47A89B0</gtr:id><gtr:outcomeId>Cizzu2K4zzj0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Discovery Partnerships with Academia</gtr:department><gtr:description>GSK Discovery Partnerships with Academia</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>572E701C-3BEE-4C03-B607-552CDDBE068C</gtr:id><gtr:outcomeId>gtytmUsz6SG</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>220087</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK grant to identify small molecules to treat alpha-1-antitrypsin deficiency</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>EE83102E-52DF-4AE9-B812-F93E22CD53EB</gtr:id><gtr:outcomeId>GyJqokFmuJf0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48546</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Rose tress Trust project grant</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:id>CFA1BA89-387F-44AB-BA29-CBDB09BB1EAD</gtr:id><gtr:outcomeId>56b32f96b80854.07739618</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK PhD Research Studentship</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>D212758D-39C8-44C7-B71F-408BE5B69FFC</gtr:id><gtr:outcomeId>VTzgE7a6rTA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>152986</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alzheimer's Research UK Grant</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>F6A41F89-7327-4E1F-AC21-802D2E164703</gtr:id><gtr:outcomeId>RP1Re5YFQq90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC/GSK CASE Industrial PhD Studentship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>A7E577E3-D7C3-4FF4-829F-A59A557F0639</gtr:id><gtr:outcomeId>XjaFXbWN86x0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>93156</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BLF Asbestos-Related Disease PhD Studentship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>British Lung Foundation (BLF)</gtr:fundingOrg><gtr:id>77417BA5-F7D7-4FCD-B616-CFD093B753BE</gtr:id><gtr:outcomeId>njxyWfZ8sMc0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2047855</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC programme grant</gtr:description><gtr:end>2021-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>N024842/1</gtr:fundingRef><gtr:id>517684F7-57D5-4424-9861-5D4B2524324E</gtr:id><gtr:outcomeId>5898f7ed4e5892.94949571</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>INSPIRE Award from Academy of Medical Sciences/Wellcome Trust</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>4FC83420-7393-4461-B6A1-5389F1896183</gtr:id><gtr:outcomeId>YmnuAeWiu9L</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT Strategic Award for CIMR</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>6F29C68E-C172-43FC-A4D5-475B5DB1811B</gtr:id><gtr:outcomeId>nJUiNi7pfAL</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3155690</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT/MRC Neurodegenerative Diseases Strategic Award</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>14A44596-31A3-4BD1-A6C5-B4E0E8E954EE</gtr:id><gtr:outcomeId>Qfqqey5QVNy0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>51121</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC/GSK CASE Industrial PhD Studentship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>75CC49E9-60B7-40F4-97FC-A21AA0D4E985</gtr:id><gtr:outcomeId>XjaFXbWN86x1</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chair, Scientific Priorities Committee, 100k Genomes, Department of Health, UK</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>25EA74CF-AE76-444F-A856-F8A516EF710D</gtr:id><gtr:outcomeId>JCm8vTf1j9K</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Small molecules are being developed to stabilise abnormal conformations in alpha-1 antitrypsin in an attempt to develop small molecules to treat this disease.</gtr:description><gtr:id>9F38B7A7-B1C9-4630-85C4-C431E18462CF</gtr:id><gtr:impact>This is an ongoing development.</gtr:impact><gtr:outcomeId>E04B5FC0F1B</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Small molecules to treat alpha-1 antitrypsin deficiency</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Monoclonal antibodies to the pathological conformer of antitrypsin</gtr:description><gtr:id>6D1F3D76-9810-4FBB-9512-605DE2D1CE4E</gtr:id><gtr:impact>This reagent has allowed us to detect pathological polymers in vitro and in vivo and is being used to screen small molecules to block the polymerisation of Z antitrypsin. These will ultimately be used to treat the associated liver and lung disease</gtr:impact><gtr:outcomeId>7CFAF96D926</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Monoclonal antibodies to the pathological conformer of antitrypsin</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>41BF4E99-FA7B-48A1-8BC8-EE28FE1D61C1</gtr:id><gtr:title>A novel interaction between aging and ER overload in a protein conformational dementia.</gtr:title><gtr:parentPublicationTitle>Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7316581a7ae9abf7901b98e5c7382a74"><gtr:id>7316581a7ae9abf7901b98e5c7382a74</gtr:id><gtr:otherNames>Schipanski A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0016-6731</gtr:issn><gtr:outcomeId>pm_12448_28_23335331</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F65AE9CB-140B-45CA-9079-633674A76AC3</gtr:id><gtr:title>Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/619a8fe02d16d22483cc100d804e6833"><gtr:id>619a8fe02d16d22483cc100d804e6833</gtr:id><gtr:otherNames>Ubhi BK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>pm_12448_28_23051772</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDC0936F-1E78-473B-BBF4-178A4E26896E</gtr:id><gtr:title>Deficiency Mutations of Alpha-1 Antitrypsin. Effects on Folding, Function, and Polymerization.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/deb0f4a6c8f3d23b81e23b1b226bebd5"><gtr:id>deb0f4a6c8f3d23b81e23b1b226bebd5</gtr:id><gtr:otherNames>Haq I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn><gtr:outcomeId>56b32e5a3a5fa7.78297384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF9C9006-0274-4D10-AB11-703AE3698AAE</gtr:id><gtr:title>Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7fb85fc86d1efa8dad1a59bd70472ca"><gtr:id>c7fb85fc86d1efa8dad1a59bd70472ca</gtr:id><gtr:otherNames>Cho MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>544be246943090.69828824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FE9AEFE-7CAB-4D13-BB4F-9474B57F91CC</gtr:id><gtr:title>Genetic control of gene expression at novel and established chronic obstructive pulmonary disease loci.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4a357b8f7e7aaebfce2eb256cab5fef"><gtr:id>c4a357b8f7e7aaebfce2eb256cab5fef</gtr:id><gtr:otherNames>Castaldi PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>544be2488a9dc3.13228889</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A46178E1-8F05-4BF5-A571-6340FD439DAF</gtr:id><gtr:title>CC-16 as a biomarker in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>COPD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430d8e459ce88909a545110552e678c5"><gtr:id>430d8e459ce88909a545110552e678c5</gtr:id><gtr:otherNames>Dickens JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1541-2563</gtr:issn><gtr:outcomeId>pm_12448_28_23030587</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB6C6E9D-E7A3-4182-BA73-B15FE28FA976</gtr:id><gtr:title>The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f1b61b7397511efbfc833269662f03a"><gtr:id>8f1b61b7397511efbfc833269662f03a</gtr:id><gtr:otherNames>Dalton LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>pm_12448_28_23412101</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D398A15F-9461-478D-B6E8-875D655F072D</gtr:id><gtr:title>Characterisation of serpin polymers in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Methods (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a12261156b163aa7165a4fc782edd347"><gtr:id>a12261156b163aa7165a4fc782edd347</gtr:id><gtr:otherNames>Belorgey D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1046-2023</gtr:issn><gtr:outcomeId>EET6XTwNvQ6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E56610A8-4A9B-46C8-8BF8-C5639E07FF92</gtr:id><gtr:title>An ECLIPSE View of Alpha-1 Antitrypsin Deficiency.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f48dd9c297e09429735c7380a03a65"><gtr:id>73f48dd9c297e09429735c7380a03a65</gtr:id><gtr:otherNames>Lomas DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>5898f630ef6864.60657184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69565C6B-95E7-4883-B3BF-B98072296EF0</gtr:id><gtr:title>The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c20455fc902a573ef7f89efc949329f"><gtr:id>5c20455fc902a573ef7f89efc949329f</gtr:id><gtr:otherNames>Coxson HO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>544be2451f7ae8.71252897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>541D7E0B-BF1D-4C83-A295-63D850CC89F6</gtr:id><gtr:title>An antibody raised against a pathogenic serpin variant induces mutant-like behaviour in the wild-type protein.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a97c91ca9350b38134a6403aba65587"><gtr:id>5a97c91ca9350b38134a6403aba65587</gtr:id><gtr:otherNames>Irving JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>56b32e5bcbe528.40463583</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F0DCB67-EC87-41BD-941F-6C0FDA64AFE9</gtr:id><gtr:title>Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7180b62b3059eaa31145b838f5630fc4"><gtr:id>7180b62b3059eaa31145b838f5630fc4</gtr:id><gtr:otherNames>Kim DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12448_28_23144326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1EB40F1-D037-4C35-A700-55E36C6694F8</gtr:id><gtr:title>Genome-wide site-specific differential methylation in the blood of individuals with Klinefelter syndrome.</gtr:title><gtr:parentPublicationTitle>Molecular reproduction and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/441ee3f3305e1f1a8f11ae66e7191ec4"><gtr:id>441ee3f3305e1f1a8f11ae66e7191ec4</gtr:id><gtr:otherNames>Wan ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1040-452X</gtr:issn><gtr:outcomeId>56b32e5ae98947.36097969</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65B466A5-1F71-416C-B9F3-23CE39C245E1</gtr:id><gtr:title>Randomised controlled trial for emphysema with a selective agonist of the ?-type retinoic acid receptor.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77ac778ad246bc672b617c411b011566"><gtr:id>77ac778ad246bc672b617c411b011566</gtr:id><gtr:otherNames>Stolk J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_12448_28_22282548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63F11C79-EA0E-4EA7-ADAB-F98F80D21D74</gtr:id><gtr:title>a(1)-antitrypsin deficiency and inflammation.</gtr:title><gtr:parentPublicationTitle>Expert review of clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99363a5a0220904537f445b11858fb4e"><gtr:id>99363a5a0220904537f445b11858fb4e</gtr:id><gtr:otherNames>Ekeowa UI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1744-666X</gtr:issn><gtr:outcomeId>qUBsftLKw5g</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1209F2B4-7E1E-4EC1-BBE4-EDDE24635365</gtr:id><gtr:title>Polymers of Z a1-antitrypsin are secreted in cell models of disease.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec720d4c8a956c8e7c4038e910170a38"><gtr:id>ec720d4c8a956c8e7c4038e910170a38</gtr:id><gtr:otherNames>Fra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>5898f632402b86.25632366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DE268C4-113C-4FEF-8F48-824D9C71B53B</gtr:id><gtr:title>Update on alpha-1 antitrypsin deficiency: New therapies.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f48dd9c297e09429735c7380a03a65"><gtr:id>73f48dd9c297e09429735c7380a03a65</gtr:id><gtr:otherNames>Lomas DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn><gtr:outcomeId>5898f631ebefa7.49344538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59FFCFCC-00AC-4D7D-B13A-1E524422BEB0</gtr:id><gtr:title>Sterol metabolism regulates neuroserpin polymer degradation in the absence of the unfolded protein response in the dementia FENIB.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f487eaac4bf435a162a9bed8f9e60bc4"><gtr:id>f487eaac4bf435a162a9bed8f9e60bc4</gtr:id><gtr:otherNames>Roussel BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12448_28_23814041</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12CDE5DF-9F6E-4019-8061-63BC87B155AC</gtr:id><gtr:title>Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58d9989ec5ec63acdb930ee8e8c99674"><gtr:id>58d9989ec5ec63acdb930ee8e8c99674</gtr:id><gtr:otherNames>Siedlinski M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>pm_12448_28_23299987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EF6406C-9202-4594-B61F-2BB4BC1DAE1F</gtr:id><gtr:title>Circulating polymers in a1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/455a84b93aefbf86b2bdcb87b72facd1"><gtr:id>455a84b93aefbf86b2bdcb87b72facd1</gtr:id><gtr:otherNames>Tan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>544be2466c2758.21233356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>665282D7-0E22-4955-9358-6F7331AA48A3</gtr:id><gtr:title>Changes in forced expiratory volume in 1 second over time in COPD.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebeabac3f65c1e9c91a9fce9147bb6b3"><gtr:id>ebeabac3f65c1e9c91a9fce9147bb6b3</gtr:id><gtr:otherNames>Vestbo J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>ZS11dudqwnG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EF552D6-633C-409C-9DF4-036768AE4402</gtr:id><gtr:title>Genetic susceptibility.</gtr:title><gtr:parentPublicationTitle>Clinics in chest medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7c6bfc1bae97372046055e2e769195"><gtr:id>6b7c6bfc1bae97372046055e2e769195</gtr:id><gtr:otherNames>Marciniak SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0272-5231</gtr:issn><gtr:outcomeId>544be24586afb6.62230718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAA68462-74A7-4599-AFAE-C5C5D69A1B20</gtr:id><gtr:title>SOX5 is a candidate gene for chronic obstructive pulmonary disease susceptibility and is necessary for lung development.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/add526325ded86beedad6c46b01ca21d"><gtr:id>add526325ded86beedad6c46b01ca21d</gtr:id><gtr:otherNames>Hersh CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>CgF1Znz7sho</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43BC4CDC-33EF-4B73-A9EE-B46C7D593786</gtr:id><gtr:title>Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebeabac3f65c1e9c91a9fce9147bb6b3"><gtr:id>ebeabac3f65c1e9c91a9fce9147bb6b3</gtr:id><gtr:otherNames>Vestbo J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>544be245b54996.84629253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44C574EB-66F6-4C97-87EA-DD0D142F0C4F</gtr:id><gtr:title>Evaluating the National Student Association of Medical Research.</gtr:title><gtr:parentPublicationTitle>Medical education</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24ddd3c5bce94e928412dcfa881d5f47"><gtr:id>24ddd3c5bce94e928412dcfa881d5f47</gtr:id><gtr:otherNames>Russell CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0308-0110</gtr:issn><gtr:outcomeId>544be2485d5118.24121641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05557222-0EE7-48A9-90F9-C8E1C7975761</gtr:id><gtr:title>Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b8d606c85bebb469a168fb34a866446"><gtr:id>0b8d606c85bebb469a168fb34a866446</gtr:id><gtr:otherNames>Brehm JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>dqAJwzD2yUF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6362C70-67C1-4F54-996A-E2AF2325B581</gtr:id><gtr:title>Lessons from ECLIPSE: a review of COPD biomarkers.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c30b5b9cff3a166a9c1fa0a5a694851b"><gtr:id>c30b5b9cff3a166a9c1fa0a5a694851b</gtr:id><gtr:otherNames>Faner R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>544be24481ffb1.67839340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E4DB376-43C8-4C64-80A4-4091C4D31FF1</gtr:id><gtr:title>Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cells.</gtr:title><gtr:parentPublicationTitle>Genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2161a7b82e55ae2cc0a43abe8c874d5d"><gtr:id>2161a7b82e55ae2cc0a43abe8c874d5d</gtr:id><gtr:otherNames>Zhou X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0888-7543</gtr:issn><gtr:outcomeId>pm_12448_28_23459001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31CE22CB-611A-4474-8A1C-A2F15C8B3618</gtr:id><gtr:title>Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/687fdae1c333df95f5a469062bd96fdc"><gtr:id>687fdae1c333df95f5a469062bd96fdc</gtr:id><gtr:otherNames>Bafadhel M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>kgg8K5RZHYd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DBE445F-8F61-4CEF-A747-237ADBEEEB88</gtr:id><gtr:title>Systemic steroid exposure is associated with differential methylation in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/441ee3f3305e1f1a8f11ae66e7191ec4"><gtr:id>441ee3f3305e1f1a8f11ae66e7191ec4</gtr:id><gtr:otherNames>Wan ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12448_28_23065012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35187AA2-3E6D-4F4C-9633-4FD66B0BBA3E</gtr:id><gtr:title>Emergence of a stage-dependent human liver disease signature with directed differentiation of alpha-1 antitrypsin-deficient iPS cells.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12d27552a32c6584b335ffca26751039"><gtr:id>12d27552a32c6584b335ffca26751039</gtr:id><gtr:otherNames>Wilson AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>56b32e5b2f7cb1.61659837</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>200C2354-33BB-430A-A161-FB5A2C4F52A0</gtr:id><gtr:title>p53 and translation attenuation regulate distinct cell cycle checkpoints during endoplasmic reticulum (ER) stress.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ce2846dbc3dd405f1e8fe7efc22c044"><gtr:id>8ce2846dbc3dd405f1e8fe7efc22c044</gtr:id><gtr:otherNames>Thomas SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12448_28_23341460</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A49430F-4836-4B82-93DE-29467D6C9BC2</gtr:id><gtr:title>Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e19be3fb69b3775df9531176b2cdb846"><gtr:id>e19be3fb69b3775df9531176b2cdb846</gtr:id><gtr:otherNames>Rabinovich RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>5898f632199bd8.86722988</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>267783DB-0E6D-4B3B-A295-BE1614EEAC5A</gtr:id><gtr:title>Characterising the association of latency with a(1)-antitrypsin polymerisation using a novel monoclonal antibody.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/455a84b93aefbf86b2bdcb87b72facd1"><gtr:id>455a84b93aefbf86b2bdcb87b72facd1</gtr:id><gtr:otherNames>Tan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>56b0f51fa37192.01115189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39D4136D-979B-4192-AF24-67BCB38C5E59</gtr:id><gtr:title>Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/441ee3f3305e1f1a8f11ae66e7191ec4"><gtr:id>441ee3f3305e1f1a8f11ae66e7191ec4</gtr:id><gtr:otherNames>Wan ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12448_28_22492999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C08E7AEB-65FA-49EE-85F5-EA7CAEC352EB</gtr:id><gtr:title>Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c1b7d2be753ec279fd0e7f928bb26a4"><gtr:id>7c1b7d2be753ec279fd0e7f928bb26a4</gtr:id><gtr:otherNames>Agusti A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_12448_28_23766334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAE5B4A5-D9A3-4DB5-A558-2B3A2D039C32</gtr:id><gtr:title>Stem cell-based therapy for a1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>Stem cell research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0396b96262cfc00bc545ab35b73fc343"><gtr:id>0396b96262cfc00bc545ab35b73fc343</gtr:id><gtr:otherNames>Rashid ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1757-6512</gtr:issn><gtr:outcomeId>pm_12448_28_22340671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8031D94A-A505-48B9-8A89-471A2CDB5A67</gtr:id><gtr:title>Suppression of A? toxicity by puromycin-sensitive aminopeptidase is independent of its proteolytic activity.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d13cbfa1c2e17b03d7503e9b907759f"><gtr:id>2d13cbfa1c2e17b03d7503e9b907759f</gtr:id><gtr:otherNames>Kruppa AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_12448_28_23911349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79E2C839-3710-4641-BD04-AD7C9CCEA413</gtr:id><gtr:title>Development of a Conceptual Model of Disease Progression for Use in Economic Modeling of Chronic Obstructive Pulmonary Disease.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b84fc7925e4deb9ac335ba7c225e1237"><gtr:id>b84fc7925e4deb9ac335ba7c225e1237</gtr:id><gtr:otherNames>Tabberer M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>5898f6312b1fb3.14848867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56097421-F833-4020-979B-6E7F13B54368</gtr:id><gtr:title>Increased ERK signalling promotes inflammatory signalling in primary airway epithelial cells expressing Z a1-antitrypsin.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/534c7795a0239195bc650835e9927b86"><gtr:id>534c7795a0239195bc650835e9927b86</gtr:id><gtr:otherNames>van 't Wout EF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12448_28_24097797</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B48A0104-424A-43D9-96CC-94AACC4B97A2</gtr:id><gtr:title>Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b21ef43b0a8052b77b575a1116164e8f"><gtr:id>b21ef43b0a8052b77b575a1116164e8f</gtr:id><gtr:otherNames>Duvoix A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_12448_28_22744884</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFBBC3A3-6381-49F6-92C5-5E2B4B3526AF</gtr:id><gtr:title>A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry.</gtr:title><gtr:parentPublicationTitle>BMC genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84d36c28055895601e2c78f59c617f72"><gtr:id>84d36c28055895601e2c78f59c617f72</gtr:id><gtr:otherNames>Lutz SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2156</gtr:issn><gtr:outcomeId>56b32e590106f1.04851007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BEB5C86-E0F5-46F1-A7B7-F48A34373585</gtr:id><gtr:title>Expression in drosophila of tandem amyloid ? peptides provides insights into links between aggregation and neurotoxicity.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/135678b9cdb3619b7a2d6bd080589f43"><gtr:id>135678b9cdb3619b7a2d6bd080589f43</gtr:id><gtr:otherNames>Speretta E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12448_28_22461632</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>188CA23D-43E9-4E6C-A6FE-9F78DC231417</gtr:id><gtr:title>Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPD.</gtr:title><gtr:parentPublicationTitle>COPD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b21ef43b0a8052b77b575a1116164e8f"><gtr:id>b21ef43b0a8052b77b575a1116164e8f</gtr:id><gtr:otherNames>Duvoix A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1541-2563</gtr:issn><gtr:outcomeId>fFm4f2VtbNq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E34CDD1B-EDE2-4EDF-ACFD-ADCA935505BE</gtr:id><gtr:title>Genome-wide association study of smoking behaviours in patients with COPD.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58d9989ec5ec63acdb930ee8e8c99674"><gtr:id>58d9989ec5ec63acdb930ee8e8c99674</gtr:id><gtr:otherNames>Siedlinski M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>tkvm1zroyou</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B587947-B6B6-49A0-919E-18F260D1149E</gtr:id><gtr:title>Susceptibility to chronic mucus hypersecretion, a genome wide association study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fff967e6d18ce0c1668d26ba8cd4496c"><gtr:id>fff967e6d18ce0c1668d26ba8cd4496c</gtr:id><gtr:otherNames>Dijkstra AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>544be246b98be8.61316277</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98200F1E-304E-4FD5-A3F6-D2E86BE1D7AC</gtr:id><gtr:title>Correction: Susceptibility to chronic mucus hypersecretion, a genome wide association study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fff967e6d18ce0c1668d26ba8cd4496c"><gtr:id>fff967e6d18ce0c1668d26ba8cd4496c</gtr:id><gtr:otherNames>Dijkstra AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56b32e5a643496.50362104</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC29F3A6-8FE3-49A2-A2FC-987EF0C3FB6F</gtr:id><gtr:title>Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report.</gtr:title><gtr:parentPublicationTitle>COPD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ba11806e1a801f96c11a216b8abc296"><gtr:id>0ba11806e1a801f96c11a216b8abc296</gtr:id><gtr:otherNames>Silverman EK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1541-2563</gtr:issn><gtr:outcomeId>TdyX3GZ3GVc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BAB9BD4-D8CC-4BA8-B2BC-CCC60158D5AA</gtr:id><gtr:title>Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8e391340193f8faabc0493a51bbc6f6"><gtr:id>f8e391340193f8faabc0493a51bbc6f6</gtr:id><gtr:otherNames>Polkey MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12448_28_23262518</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>514C4A4F-AD31-45D7-9964-CBC6ADD744D3</gtr:id><gtr:title>Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f17aa310c456899a2c37eba069f7dab"><gtr:id>4f17aa310c456899a2c37eba069f7dab</gtr:id><gtr:otherNames>Cheng DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12448_28_23947473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE038DBB-AC33-4543-A265-ED4385E6C8A3</gtr:id><gtr:title>Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da7209028fd2fad71673a1ec88e0451c"><gtr:id>da7209028fd2fad71673a1ec88e0451c</gtr:id><gtr:otherNames>McDonald ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn><gtr:outcomeId>544be246e7d625.35828986</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7062287E-DB51-4DA5-A9F9-EB6336475865</gtr:id><gtr:title>Function of monocytes and monocyte-derived macrophages in a1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30cd61943b2bee3fd9ce96dc8bf1fc16"><gtr:id>30cd61943b2bee3fd9ce96dc8bf1fc16</gtr:id><gtr:otherNames>Van't Wout EF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>544be248bca2e3.74534144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE13A995-9599-4C70-BAA0-49AAA54BC795</gtr:id><gtr:title>The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4a357b8f7e7aaebfce2eb256cab5fef"><gtr:id>c4a357b8f7e7aaebfce2eb256cab5fef</gtr:id><gtr:otherNames>Castaldi PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn><gtr:outcomeId>MaPvPqEMUV8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC3C9A24-3578-459E-B09B-009ACDD8BBF9</gtr:id><gtr:title>The COPD Biomarker Qualification Consortium (CBQC).</gtr:title><gtr:parentPublicationTitle>COPD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/379297c6ac230b62a51de0319f9a6296"><gtr:id>379297c6ac230b62a51de0319f9a6296</gtr:id><gtr:otherNames>Casaburi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1541-2563</gtr:issn><gtr:outcomeId>pm_12448_28_23713597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC88B00C-33F6-463C-8469-1FC7F61EDE35</gtr:id><gtr:title>Disease-related amyloidogenic variants of human lysozyme trigger the unfolded protein response and disturb eye development in Drosophila melanogaster.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf5edbd3f4fbad35c3ab1d019e9abc44"><gtr:id>bf5edbd3f4fbad35c3ab1d019e9abc44</gtr:id><gtr:otherNames>Kumita JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>MwXXhY9YGiV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA7720DB-78D6-4FF9-8CE1-39DFDD1A794D</gtr:id><gtr:title>Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2cd87a0c4aaae349d3dbb84a5fa1bcc8"><gtr:id>2cd87a0c4aaae349d3dbb84a5fa1bcc8</gtr:id><gtr:otherNames>Albert P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_12448_28_22696176</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4634159-E45C-4933-B02D-CB328926A9DF</gtr:id><gtr:title>Progressive myoclonus epilepsy associated with neuroserpin inclusion bodies (neuroserpinosis).</gtr:title><gtr:parentPublicationTitle>Epileptic disorders : international epilepsy journal with videotape</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f487eaac4bf435a162a9bed8f9e60bc4"><gtr:id>f487eaac4bf435a162a9bed8f9e60bc4</gtr:id><gtr:otherNames>Roussel BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1294-9361</gtr:issn><gtr:outcomeId>5898f630a76800.96874269</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D183CD9-E9FA-4966-B27F-6D37D1F699DC</gtr:id><gtr:title>An integrative approach combining ion mobility mass spectrometry, X-ray crystallography, and nuclear magnetic resonance spectroscopy to study the conformational dynamics of a1 -antitrypsin upon ligand binding.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05ef27b40b42c70c0c49913ddaf4a28e"><gtr:id>05ef27b40b42c70c0c49913ddaf4a28e</gtr:id><gtr:otherNames>Nyon MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>56b32e5aae23f8.21711900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F900288-5A2E-45D3-B252-4337F2F7EE69</gtr:id><gtr:title>The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e8a09d2e84db2427dbc07a19677f704"><gtr:id>8e8a09d2e84db2427dbc07a19677f704</gtr:id><gtr:otherNames>Pini L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn><gtr:outcomeId>544be247c6d037.31277803</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>565CCE1C-ADAF-4B28-8FF7-2251695B4E21</gtr:id><gtr:title>The central molecular clock is robust in the face of behavioural arrhythmia in a Drosophila model of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bdf261a22d7c6fdb5177fdf04b8c78d"><gtr:id>2bdf261a22d7c6fdb5177fdf04b8c78d</gtr:id><gtr:otherNames>Chen KF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>544be2463d5cd3.24042094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB8CBD78-C835-4617-9489-28A3FDCFCF78</gtr:id><gtr:title>Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80110494780b9dee6cc2ddf0a83d5192"><gtr:id>80110494780b9dee6cc2ddf0a83d5192</gtr:id><gtr:otherNames>Yonchuk JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>56b32e59d79ba2.52583283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C11E8F0-CBBF-431A-A242-2052E21A9297</gtr:id><gtr:title>Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8a3b7b40a5ac214de7b3b36a37b4680"><gtr:id>f8a3b7b40a5ac214de7b3b36a37b4680</gtr:id><gtr:otherNames>Williams MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>544be245495342.92640058</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D15BC6E6-A8C7-4B62-BA62-B569E3FBC315</gtr:id><gtr:title>Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b25ac1b502ae4410ca8c09bac000448f"><gtr:id>b25ac1b502ae4410ca8c09bac000448f</gtr:id><gtr:otherNames>Agust? A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12448_28_22624038</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FEB77DB-578D-4CF9-B9D3-D6821CFE6CBE</gtr:id><gtr:title>Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9eb4005432a87e0811793ab07779eb83"><gtr:id>9eb4005432a87e0811793ab07779eb83</gtr:id><gtr:otherNames>Briggs AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>5898f6319f9e79.22048033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7D19886-1138-479F-9278-89CBE0C0E2EE</gtr:id><gtr:title>Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4377ed4861af442d6d8939bfb897ce6"><gtr:id>a4377ed4861af442d6d8939bfb897ce6</gtr:id><gtr:otherNames>Liu B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>KiLR7Ez4WhT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A589FFEB-71E7-4B15-89D7-99CC1E3953C9</gtr:id><gtr:title>Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55ea5e8e0701a4bf9fd4b547fc5695b7"><gtr:id>55ea5e8e0701a4bf9fd4b547fc5695b7</gtr:id><gtr:otherNames>Wilk JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12448_28_22837378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94B0E9C8-098A-4BE4-8BFF-A24B190FDB9C</gtr:id><gtr:title>A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7fb85fc86d1efa8dad1a59bd70472ca"><gtr:id>c7fb85fc86d1efa8dad1a59bd70472ca</gtr:id><gtr:otherNames>Cho MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_12448_28_22080838</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A6CAA34-084B-4C79-97FB-22D0981A215E</gtr:id><gtr:title>Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.</gtr:title><gtr:parentPublicationTitle>Journal of cachexia, sarcopenia and muscle</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b96f7cdff7f3fdd155e4d36ffb677607"><gtr:id>b96f7cdff7f3fdd155e4d36ffb677607</gtr:id><gtr:otherNames>McDonald MN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2190-5991</gtr:issn><gtr:outcomeId>5898f630541d05.95026597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>300AAC88-C8E2-450F-B5F4-889CA2C84CBC</gtr:id><gtr:title>Influence of SIGLEC9 polymorphisms on COPD phenotypes including exacerbation frequency.</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02ff87a0214e1ef8bfa29dc297d3249d"><gtr:id>02ff87a0214e1ef8bfa29dc297d3249d</gtr:id><gtr:otherNames>Ishii T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>5898f630855e53.70091660</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F270D683-5830-4597-912C-41958F251736</gtr:id><gtr:title>a1-Antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Disease primers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/451f9355458a21582f41918901790b0e"><gtr:id>451f9355458a21582f41918901790b0e</gtr:id><gtr:otherNames>Greene CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2056-676X</gtr:issn><gtr:outcomeId>5898f631536992.90788671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BB6B6B6-C05D-4B0E-B33A-DA038000A901</gtr:id><gtr:title>Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Journal of the American Medical Directors Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ef40081c388c4bd94531b42e5a83f61"><gtr:id>8ef40081c388c4bd94531b42e5a83f61</gtr:id><gtr:otherNames>Spruit MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1525-8610</gtr:issn><gtr:outcomeId>jXk5R71Q9UC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDAC6FED-3258-4C28-B79E-671BC7AEC0F2</gtr:id><gtr:title>Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e84fd250e30ef8a431f1f3fdbadfd5d1"><gtr:id>e84fd250e30ef8a431f1f3fdbadfd5d1</gtr:id><gtr:otherNames>Rennard SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>56b0f51fdecaf9.02431583</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87B534B7-CAB5-44B3-84F2-1106428F97CA</gtr:id><gtr:title>The effects of weekly augmentation therapy in patients with PiZZ a1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>International journal of chronic obstructive pulmonary disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f4d427e2208e7f24f572502465bf32e"><gtr:id>2f4d427e2208e7f24f572502465bf32e</gtr:id><gtr:otherNames>Schmid ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1176-9106</gtr:issn><gtr:outcomeId>pm_12448_28_23055718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFE5E00A-6017-485E-AFDE-1D630DA7BAF3</gtr:id><gtr:title>Evaluating the role of inflammation in chronic airways disease: the ERICA study.</gtr:title><gtr:parentPublicationTitle>COPD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2cdc70e4662d11008f38c98b5a36a056"><gtr:id>2cdc70e4662d11008f38c98b5a36a056</gtr:id><gtr:otherNames>Mohan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1541-2563</gtr:issn><gtr:outcomeId>544be2471d5ce9.96082506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5222BBB-89B6-4EF4-9BA4-603006CC1051</gtr:id><gtr:title>Genetic association between human chitinases and lung function in COPD.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c9df4d38e14b89bc7226924a27ba79b"><gtr:id>3c9df4d38e14b89bc7226924a27ba79b</gtr:id><gtr:otherNames>Aminuddin F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>pm_12448_28_22200767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A20A59A-EACC-4CCC-A98D-DA9E2707FBF5</gtr:id><gtr:title>Detection of early locomotor abnormalities in a Drosophila model of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e38e486731c929953d5e646e4801bba"><gtr:id>2e38e486731c929953d5e646e4801bba</gtr:id><gtr:otherNames>Jahn TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>G3jPEWfpqxV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D69B2C20-932D-4894-8AD4-B98A68B65FC3</gtr:id><gtr:title>ANCA-associated vasculitis is linked to carriage of the Z allele of a1 antitrypsin and its polymers.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/023030f380b3591be679eafd445a0771"><gtr:id>023030f380b3591be679eafd445a0771</gtr:id><gtr:otherNames>Morris H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>FcsB7fCF7Js</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2C86FBC-549F-46D6-B511-42830084A3BC</gtr:id><gtr:title>Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0567f8eebf7db3e5c72de58de70706ff"><gtr:id>0567f8eebf7db3e5c72de58de70706ff</gtr:id><gtr:otherNames>Lee JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn><gtr:outcomeId>544be2482d83b1.01691031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAB218FB-B209-418B-94D8-57ECC72EAAF6</gtr:id><gtr:title>Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cfd6a4c493c3912e1e15f9c9705d0af"><gtr:id>0cfd6a4c493c3912e1e15f9c9705d0af</gtr:id><gtr:otherNames>Qiu W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12448_28_22161163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74251E61-55EE-4606-A72A-9B8B74B28FF6</gtr:id><gtr:title>Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis.</gtr:title><gtr:parentPublicationTitle>Drug design, development and therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430d8e459ce88909a545110552e678c5"><gtr:id>430d8e459ce88909a545110552e678c5</gtr:id><gtr:otherNames>Dickens JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1177-8881</gtr:issn><gtr:outcomeId>PH4RVVP2Uhn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B4DBF36-BE8D-4FAD-BC5C-BCCE69594F56</gtr:id><gtr:title>An antibody that prevents serpin polymerisation acts by inducing a novel allosteric behaviour.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3a0dd24897f8715dfa8b6621969d901"><gtr:id>a3a0dd24897f8715dfa8b6621969d901</gtr:id><gtr:otherNames>Motamedi-Shad N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5898f631799f06.06941091</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7464A2F-9060-42DF-B188-BF3F911816AA</gtr:id><gtr:title>Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infection.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36e6bd83dfd373c441dfe6211f736a6c"><gtr:id>36e6bd83dfd373c441dfe6211f736a6c</gtr:id><gtr:otherNames>Chen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>pm_12448_28_23774438</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B121B4B-FD24-4017-9ECA-7789E35CD694</gtr:id><gtr:title>A single-chain variable fragment intrabody prevents intracellular polymerization of Z a1-antitrypsin while allowing its antiproteinase activity.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e91db47f6a14985649e44551f7e7f2"><gtr:id>b8e91db47f6a14985649e44551f7e7f2</gtr:id><gtr:otherNames>Ord??ez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>56b32e5b9c83d4.04409914</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C9A464E-FDED-48CC-A893-EDAD71361AAC</gtr:id><gtr:title>Unravelling the twists and turns of the serpinopathies.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f487eaac4bf435a162a9bed8f9e60bc4"><gtr:id>f487eaac4bf435a162a9bed8f9e60bc4</gtr:id><gtr:otherNames>Roussel BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>YdcAZQWLTpH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75EE991E-A4B2-4A59-A73E-7294D5733746</gtr:id><gtr:title>Prevalence and risk factors for liver involvement in individuals with PiZZ-related lung disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f938bfcd1d380ce5e5e56dda02b7d4c"><gtr:id>4f938bfcd1d380ce5e5e56dda02b7d4c</gtr:id><gtr:otherNames>Dawwas MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12448_28_23262512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E224741-C485-401B-8AEC-C8DD0D080C02</gtr:id><gtr:title>IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0567f8eebf7db3e5c72de58de70706ff"><gtr:id>0567f8eebf7db3e5c72de58de70706ff</gtr:id><gtr:otherNames>Lee JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn><gtr:outcomeId>544be2476e3e32.20779140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D210626D-7DB2-4AE5-B4E8-872E7CCC496D</gtr:id><gtr:title>Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/687fdae1c333df95f5a469062bd96fdc"><gtr:id>687fdae1c333df95f5a469062bd96fdc</gtr:id><gtr:otherNames>Bafadhel M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12448_28_22447964</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A198FF43-5B2E-4E50-B533-4D4965A3F85C</gtr:id><gtr:title>Coordinate regulation of eIF2a phosphorylation by PPP1R15 and GCN2 is required during Drosophila development.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0c027531dbd4f201d7cb44046a044ee"><gtr:id>f0c027531dbd4f201d7cb44046a044ee</gtr:id><gtr:otherNames>Malzer E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_12448_28_23418347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BDA0BFF-C0D3-4145-BAC5-DC39502C1187</gtr:id><gtr:title>Does Protease-Antiprotease Imbalance Explain Chronic Obstructive Pulmonary Disease?</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f48dd9c297e09429735c7380a03a65"><gtr:id>73f48dd9c297e09429735c7380a03a65</gtr:id><gtr:otherNames>Lomas DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>5898f631c0a6d4.80920513</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDFBCA8C-A8A6-47A6-824B-E46CF753603F</gtr:id><gtr:title>Metabolic profiling detects biomarkers of protein degradation in COPD patients.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/619a8fe02d16d22483cc100d804e6833"><gtr:id>619a8fe02d16d22483cc100d804e6833</gtr:id><gtr:otherNames>Ubhi BK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_12448_28_22183483</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F0E600E-789A-4DDB-A286-B844E99ABB98</gtr:id><gtr:title>Therapeutic target-site variability in a1-antitrypsin characterized at high resolution.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91e8300a8f049deda4481c04366f44c3"><gtr:id>91e8300a8f049deda4481c04366f44c3</gtr:id><gtr:otherNames>Patschull AO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>pm_12448_28_22139150</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99E5BF21-CF7E-47FD-9B7E-AA6FF1D38F7D</gtr:id><gtr:title>Twenty years of polymers: a personal perspective on alpha-1 antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>COPD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f48dd9c297e09429735c7380a03a65"><gtr:id>73f48dd9c297e09429735c7380a03a65</gtr:id><gtr:otherNames>Lomas DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1541-2563</gtr:issn><gtr:outcomeId>pm_12448_28_23527623</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BC08BB3-4C0E-42B7-BE8B-E2391D852AC5</gtr:id><gtr:title>Endoplasmic reticulum polymers impair luminal protein mobility and sensitize to cellular stress in alpha1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e91db47f6a14985649e44551f7e7f2"><gtr:id>b8e91db47f6a14985649e44551f7e7f2</gtr:id><gtr:otherNames>Ord??ez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>pm_12448_28_23197448</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA1D1C18-6C93-4A22-88AC-758F180B288F</gtr:id><gtr:title>The molecular and cellular pathology of a1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>Trends in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f7ec6cd45f2cd59b79537e29826f8d6"><gtr:id>2f7ec6cd45f2cd59b79537e29826f8d6</gtr:id><gtr:otherNames>Gooptu B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-4914</gtr:issn><gtr:outcomeId>544be244e073c3.03376421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A784FB9-ED07-45C2-8ED5-4DEBFC7483CE</gtr:id><gtr:title>The iFly tracking system for an automated locomotor and behavioural analysis of Drosophila melanogaster.</gtr:title><gtr:parentPublicationTitle>Integrative biology : quantitative biosciences from nano to macro</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77022d2c91419c4674e064367803e5db"><gtr:id>77022d2c91419c4674e064367803e5db</gtr:id><gtr:otherNames>Kohlhoff KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-9694</gtr:issn><gtr:outcomeId>twY9V5ZNNWD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77DD3FE6-B186-4DB4-B501-44959E61D6F6</gtr:id><gtr:title>Structural dynamics associated with intermediate formation in an archetypal conformational disease.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05ef27b40b42c70c0c49913ddaf4a28e"><gtr:id>05ef27b40b42c70c0c49913ddaf4a28e</gtr:id><gtr:otherNames>Nyon MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_12448_28_22405009</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66518FB7-8A1F-4F60-82BD-A5DCA99FF4C2</gtr:id><gtr:title>The TRiC/CCT chaperone is implicated in Alzheimer's disease based on patient GWAS and an RNAi screen in A?-expressing Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36688dfd02cdf9038c075b02a278b29d"><gtr:id>36688dfd02cdf9038c075b02a278b29d</gtr:id><gtr:otherNames>Khabirova E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>544be24749ca93.57771005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>120E284C-2844-45D1-B2A1-0B5052CC5DCD</gtr:id><gtr:title>The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6199e32795cb3f2d9d784d1c977e2f6e"><gtr:id>6199e32795cb3f2d9d784d1c977e2f6e</gtr:id><gtr:otherNames>Rodr?guez-Gonz?lez R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>QqPRLmU9SKv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E289C5E-65E0-4181-B320-4C57123C9717</gtr:id><gtr:title>Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4a357b8f7e7aaebfce2eb256cab5fef"><gtr:id>c4a357b8f7e7aaebfce2eb256cab5fef</gtr:id><gtr:otherNames>Castaldi PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>bBapafBsuQq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09668544-E6E7-4756-B210-E62371824878</gtr:id><gtr:title>Molecular pathogenesis of alpha-1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>Revue des maladies respiratoires</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b21ef43b0a8052b77b575a1116164e8f"><gtr:id>b21ef43b0a8052b77b575a1116164e8f</gtr:id><gtr:otherNames>Duvoix A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0761-8425</gtr:issn><gtr:outcomeId>56b0f51f693289.80755913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C2CFA07-88D1-495A-AC55-2ADD633EC341</gtr:id><gtr:title>Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55269e4f2ba4a9d2aa52598d6f0ecc62"><gtr:id>55269e4f2ba4a9d2aa52598d6f0ecc62</gtr:id><gtr:otherNames>Celli BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_12448_28_22427534</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13D1703A-414A-4BAC-AC05-23B911830C9D</gtr:id><gtr:title>One-year change in health status and subsequent outcomes in COPD.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e664734022dc98c793c5ff0b77dcdc1"><gtr:id>6e664734022dc98c793c5ff0b77dcdc1</gtr:id><gtr:otherNames>Wilke S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>56b32e5b631a90.89390072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18FC8B79-6D2F-438A-AEF4-183071A81872</gtr:id><gtr:title>The serpinopathies studying serpin polymerization in vivo.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a97c91ca9350b38134a6403aba65587"><gtr:id>5a97c91ca9350b38134a6403aba65587</gtr:id><gtr:otherNames>Irving JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>pm_12448_28_22078544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B0FA734-A638-4F37-898B-5FEBE2B7D9DC</gtr:id><gtr:title>Endoplasmic reticulum dysfunction in neurological disease.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f487eaac4bf435a162a9bed8f9e60bc4"><gtr:id>f487eaac4bf435a162a9bed8f9e60bc4</gtr:id><gtr:otherNames>Roussel BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_12448_28_23237905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6F3D0CF-0011-4C3F-8B2E-D2FAB32BE2F1</gtr:id><gtr:title>Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes?</gtr:title><gtr:parentPublicationTitle>Annals of nutrition &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62315519662b41535db1e65840e882f2"><gtr:id>62315519662b41535db1e65840e882f2</gtr:id><gtr:otherNames>Rutten EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0250-6807</gtr:issn><gtr:outcomeId>pm_12448_28_24216978</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2AE7737-EE1E-4CB2-BC57-84E09EE563CC</gtr:id><gtr:title>An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f48dd9c297e09429735c7380a03a65"><gtr:id>73f48dd9c297e09429735c7380a03a65</gtr:id><gtr:otherNames>Lomas DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-2700</gtr:issn><gtr:outcomeId>pm_12448_28_22090363</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0728C7FE-5D22-4765-A3EA-6BC037435DD4</gtr:id><gtr:title>Altered native stability is the dominant basis for susceptibility of a1-antitrypsin mutants to polymerization.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a97c91ca9350b38134a6403aba65587"><gtr:id>5a97c91ca9350b38134a6403aba65587</gtr:id><gtr:otherNames>Irving JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>544be245de4e64.91783831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>140D334D-A9EB-42CB-BFA7-AF75FF22DB7B</gtr:id><gtr:title>Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3a2a9d5c70bece3cd3557dd2133b6af"><gtr:id>e3a2a9d5c70bece3cd3557dd2133b6af</gtr:id><gtr:otherNames>Sin DD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>ocayYV1izcV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A7DD6D8-4F3A-41B8-89C2-D23526D4C101</gtr:id><gtr:title>Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort.</gtr:title><gtr:parentPublicationTitle>Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/938ab83d7dbad617c19ca555cfb8111b"><gtr:id>938ab83d7dbad617c19ca555cfb8111b</gtr:id><gtr:otherNames>Miller J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0954-6111</gtr:issn><gtr:outcomeId>pm_12448_28_23791463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73FDB598-F6A8-4A49-8609-4B6B31AE214B</gtr:id><gtr:title>DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0567f8eebf7db3e5c72de58de70706ff"><gtr:id>0567f8eebf7db3e5c72de58de70706ff</gtr:id><gtr:otherNames>Lee JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn><gtr:outcomeId>544be2479a1126.63039300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDED9D40-D966-4896-9169-0E30F690A585</gtr:id><gtr:title>Reactive centre loop mutants of a-1-antitrypsin reveal position-specific effects on intermediate formation along the polymerization pathway.</gtr:title><gtr:parentPublicationTitle>Bioscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/deb0f4a6c8f3d23b81e23b1b226bebd5"><gtr:id>deb0f4a6c8f3d23b81e23b1b226bebd5</gtr:id><gtr:otherNames>Haq I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0144-8463</gtr:issn><gtr:outcomeId>pm_12448_28_23659468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D1EAFB2-5931-4834-B3AE-FF7D75038663</gtr:id><gtr:title>Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fff967e6d18ce0c1668d26ba8cd4496c"><gtr:id>fff967e6d18ce0c1668d26ba8cd4496c</gtr:id><gtr:otherNames>Dijkstra AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>544be247f26208.69731028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B0BAD04-0324-419F-B554-A22A8F3EBB58</gtr:id><gtr:title>The endoplasmic reticulum remains functionally connected by vesicular transport after its fragmentation in cells expressing Z-a1-antitrypsin.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430d8e459ce88909a545110552e678c5"><gtr:id>430d8e459ce88909a545110552e678c5</gtr:id><gtr:otherNames>Dickens JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>5898f630ccfcb9.01993347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3137CC18-46CC-4B1A-AB63-CAC47254BB1A</gtr:id><gtr:title>On the follow-up of genome-wide association studies: an overall test for the most promising SNPs.</gtr:title><gtr:parentPublicationTitle>Genetic epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e63bd1e8a18ac44f18f5de6316cdd22b"><gtr:id>e63bd1e8a18ac44f18f5de6316cdd22b</gtr:id><gtr:otherNames>Lipman PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0741-0395</gtr:issn><gtr:outcomeId>dm8cfJ5np2W</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06C51C7E-74BB-4CC1-B5B8-7B31CD65882F</gtr:id><gtr:title>Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD.</gtr:title><gtr:parentPublicationTitle>Chronic obstructive pulmonary diseases (Miami, Fla.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5366bc2f013a95275bf0fc5eb7cab2f2"><gtr:id>5366bc2f013a95275bf0fc5eb7cab2f2</gtr:id><gtr:otherNames>Mannino DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2372-952X</gtr:issn><gtr:outcomeId>56b0f52022fe14.15881865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02A3A959-310A-42D7-93A9-90B927AD1FBB</gtr:id><gtr:title>Targeted gene correction of a1-antitrypsin deficiency in induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be1bae898aea75410b34af4f816f8a7a"><gtr:id>be1bae898aea75410b34af4f816f8a7a</gtr:id><gtr:otherNames>Yusa K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>CrNXaHRjGw4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A488632-31A6-4DA9-A627-A2215A5C4DE8</gtr:id><gtr:title>COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430d8e459ce88909a545110552e678c5"><gtr:id>430d8e459ce88909a545110552e678c5</gtr:id><gtr:otherNames>Dickens JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn><gtr:outcomeId>pm_12448_28_22054035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3790757D-EEF8-4356-8D72-58B97AFADEA6</gtr:id><gtr:title>Genetics of sputum gene expression in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cfd6a4c493c3912e1e15f9c9705d0af"><gtr:id>0cfd6a4c493c3912e1e15f9c9705d0af</gtr:id><gtr:otherNames>Qiu W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>hs7Sjv8XWUL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D93325F7-BAC8-4277-B989-E75C87ADE49B</gtr:id><gtr:title>Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke.</gtr:title><gtr:parentPublicationTitle>Journal of translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6199e32795cb3f2d9d784d1c977e2f6e"><gtr:id>6199e32795cb3f2d9d784d1c977e2f6e</gtr:id><gtr:otherNames>Rodr?guez-Gonz?lez R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1479-5876</gtr:issn><gtr:outcomeId>Jhk7DqCvZhp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAEBE7CE-FFC2-4A67-A768-1895F693AC64</gtr:id><gtr:title>Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary Disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/844cdfad3fa538e575be3a8c1298d1dd"><gtr:id>844cdfad3fa538e575be3a8c1298d1dd</gtr:id><gtr:otherNames>Hobbs BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>56b32e58c4c963.51314280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A08EC3B-CB95-4F7E-A12E-5AD5DE00D143</gtr:id><gtr:title>Interactions between N-linked glycosylation and polymerisation of neuroserpin within the endoplasmic reticulum.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40c739b4f07195cb05078715b6e21185"><gtr:id>40c739b4f07195cb05078715b6e21185</gtr:id><gtr:otherNames>Moriconi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>56b32e59a9ca74.99807174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>760714F3-8663-4898-A348-47081B9241C3</gtr:id><gtr:title>Statistical Modeling of Disease Progression for Chronic Obstructive Pulmonary Disease Using Data from the ECLIPSE Study.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24b685b6eb3c1c1dedcb12f76b6f1ebb"><gtr:id>24b685b6eb3c1c1dedcb12f76b6f1ebb</gtr:id><gtr:otherNames>Exuzides A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>56b32e59423993.20262811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A9E1214-B023-4429-BC49-184B39BE2531</gtr:id><gtr:title>Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c77ae5e46ee47af89880774f7a24bbcc"><gtr:id>c77ae5e46ee47af89880774f7a24bbcc</gtr:id><gtr:otherNames>Hansel NN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>pm_12448_28_22986903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F375348B-61E5-4699-B8F8-52C0C27172FF</gtr:id><gtr:title>Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>BMC pulmonary medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c9df4d38e14b89bc7226924a27ba79b"><gtr:id>3c9df4d38e14b89bc7226924a27ba79b</gtr:id><gtr:otherNames>Aminuddin F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2466</gtr:issn><gtr:outcomeId>pm_12448_28_24192154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>169ED641-2831-4C5A-BEB6-B64F613A53A5</gtr:id><gtr:title>Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da7209028fd2fad71673a1ec88e0451c"><gtr:id>da7209028fd2fad71673a1ec88e0451c</gtr:id><gtr:otherNames>McDonald ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>544be246152db9.86837827</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901786</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>986F1CAE-CC43-4D59-8F85-A91971E4C4BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Other</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>